OncoLens delivers a path to dramatically improving the productivity of multidisciplinary team (MDT) members as they prepare for and conduct virtual, in-person, and hybrid cancer conferences. We provide a single, comprehensive patient view that is enhanced and enriched by conference activities. And the data, insights, and plans that come out of the tumor board/cancer conference serve as a throughline that supports the entire patient care journey.

OncoLens empowers cancer programs by lowering data barriers and increasing visibility into referral opportunities. This includes in-network referrals to specialty procedures such as bone marrow transplant, CAR-T, sub-specialists, and the expanded referral network. The clinical trial capabilities embedded within the solution leverage AI-powered technology to identify and prioritize clinical trial opportunities. And all of this is delivered through secure, HIPAA compliant platform.

OncoLens helps cancer programs maintain COC, NAPBC, and NAPRC accreditation; document and disseminate best practices and protocols; and drive consistency and adherence across providers. The patient data captured within the platform delivers a complete view into the MDC care program and helps ensure the measurability and usability of care insights. And, OncoLens links data back to the patient journey to drive a complete understanding of care delivery, care experience, and care outcomes.

OncoLens helps ensure that every cancer patient receives an individualized survivorship care plan that includes guidelines for monitoring and maintaining optimal health after cancer treatment. The value of this goes beyond plan generation to drive consistency of care, extend patient loyalty, and improve the perception of care delivered by the network. By enabling the MDC care approach through to survivorship, OncoLens helps amplify the value of the ongoing patient relationship.